398 related articles for article (PubMed ID: 25738841)
1. Identifying prognostic features by bottom-up approach and correlating to drug repositioning.
Li W; Yu J; Lian B; Sun H; Li J; Zhang M; Li L; Li Y; Liu Q; Xie L
PLoS One; 2015; 10(3):e0118672. PubMed ID: 25738841
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties.
Cai J; Li B; Zhu Y; Fang X; Zhu M; Wang M; Liu S; Jiang X; Zheng J; Zhang X; Chen P
EBioMedicine; 2017 May; 19():18-30. PubMed ID: 28434945
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Novel Drugs for Hepatocellular Carcinoma Based on Multi-Source Random Walk.
Yu L; Su R; Wang B; Zhang L; Zou Y; Zhang J; Gao L
IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(4):966-977. PubMed ID: 27076463
[TBL] [Abstract][Full Text] [Related]
4. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
[TBL] [Abstract][Full Text] [Related]
5. Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation.
Zhang Y; Guo X; Yang M; Yu L; Li Z; Lin N
Mol Biosyst; 2014 Feb; 10(2):215-22. PubMed ID: 24247267
[TBL] [Abstract][Full Text] [Related]
6. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.
Lim HY; Sohn I; Deng S; Lee J; Jung SH; Mao M; Xu J; Wang K; Shi S; Joh JW; Choi YL; Park CK
Ann Surg Oncol; 2013 Nov; 20(12):3747-53. PubMed ID: 23800896
[TBL] [Abstract][Full Text] [Related]
7. A Computational Framework to Identify Transcriptional and Network Differences between Hepatocellular Carcinoma and Normal Liver Tissue and Their Applications in Repositioning Drugs.
Hu A; Wei Z; Zheng Z; Luo B; Yi J; Zhou X; Zeng C
Biomed Res Int; 2021; 2021():9921195. PubMed ID: 34604388
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
[TBL] [Abstract][Full Text] [Related]
9. Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma.
Ivanovska I; Zhang C; Liu AM; Wong KF; Lee NP; Lewis P; Philippar U; Bansal D; Buser C; Scott M; Mao M; Poon RT; Fan ST; Cleary MA; Luk JM; Dai H
PLoS One; 2011; 6(9):e24582. PubMed ID: 21949730
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
[TBL] [Abstract][Full Text] [Related]
11. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis.
Hua S; Ji Z; Quan Y; Zhan M; Wang H; Li W; Li Y; He X; Lu L
Aging (Albany NY); 2020 Mar; 12(6):5439-5468. PubMed ID: 32213663
[TBL] [Abstract][Full Text] [Related]
14. Random gene sets in predicting survival of patients with hepatocellular carcinoma.
Itzel T; Spang R; Maass T; Munker S; Roessler S; Ebert MP; Schlitt HJ; Herr W; Evert M; Teufel A
J Mol Med (Berl); 2019 Jun; 97(6):879-888. PubMed ID: 31001651
[TBL] [Abstract][Full Text] [Related]
15. Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures.
Braconi C; Meng F; Swenson E; Khrapenko L; Huang N; Patel T
Cancer; 2009 Aug; 115(16):3738-48. PubMed ID: 19514085
[TBL] [Abstract][Full Text] [Related]
16. Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma.
Zhai X; Xue Q; Liu Q; Guo Y; Chen Z
Mol Med Rep; 2017 Sep; 16(3):3253-3261. PubMed ID: 28713927
[TBL] [Abstract][Full Text] [Related]
17. Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation.
Miltiadous O; Sia D; Hoshida Y; Fiel MI; Harrington AN; Thung SN; Tan PS; Dong H; Revill K; Chang CY; Roayaie S; Byrne TJ; Mazzaferro V; Rakela J; Florman S; Schwartz M; Llovet JM
J Hepatol; 2015 Dec; 63(6):1368-77. PubMed ID: 26220754
[TBL] [Abstract][Full Text] [Related]
18. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B.
Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC
J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223
[TBL] [Abstract][Full Text] [Related]
19. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.
Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM
Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.
Villanueva A; Portela A; Sayols S; Battiston C; Hoshida Y; Méndez-González J; Imbeaud S; Letouzé E; Hernandez-Gea V; Cornella H; Pinyol R; Solé M; Fuster J; Zucman-Rossi J; Mazzaferro V; Esteller M; Llovet JM;
Hepatology; 2015 Jun; 61(6):1945-56. PubMed ID: 25645722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
